共 50 条
- [21] Previous Transurethral Resection (TURP) is not a Contraindication for Interstitial High Dose Rate (HDR) Brachytherapy for Early Stage Prostate Cancer AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 202 - 202
- [22] Interstitial High Dose Rate (HDR) brachytherapy plus IMRT versus HDR monotherapy for early stage prostate cancer: A report of 363 cases INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S290 - S290
- [25] Interstitial High Dose Rate (HDR) brachytherapy for early stage breast cancer: A report of 136 cases INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S229 - S229
- [26] Interstitial High Dose Rate (HDR) brachytherapy plus IMRT vs. HDR monotherapy for early stage prostate cancer: A report of 315 cases INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S363 - S363
- [27] Interstitial High Dose Rate (HDR) Brachytherapy as Monotherapy for Early Stage Prostate Cancer: Median 8 Year Results in 312 Patients INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S147 - S147
- [29] Interstitial High Dose Rate (HDR) Brachytherapy as Monotherapy for Early Stage Prostate Cancer: Median 8 Year Results in 308 Patients AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 201 - 201